miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathwayManman Xu, Shuzhong Yao|International Journal of Oncology|2018Cited by 53
Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway InhibitionManman Xu, Jie Li, Cuimiao Zheng et al.|Cancers|2022Cited by 10